Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

CUSIP: 92539P101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
89,600,000
Total 13F shares
61,868,280
Share change
-1,389,013
Total reported value
$1,159,985,777
Put/Call ratio
125%
Price per share
$18.75
Number of holders
117
Value change
-$19,845,731
Number of buys
61
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 92539P101?
CUSIP 92539P101 identifies VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q2 2023

As of 30 Jun 2023, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,868,280 shares. The largest 10 holders included Alphabet Inc., FMR LLC, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FEDERATED HERMES, INC., Casdin Capital, LLC, Sumitomo Mitsui Trust Holdings, Inc., and Nikko Asset Management Americas, Inc.. This page lists 117 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.